 fund  national  institutes  health  clinical  trial  low  dose  naltrexone  multiple  sclerosis  generic  drug  treatment  low  dose  naltrexone  ldn  effective  drug  today  preventing  disability  caused  multiple  sclerosis  doctors  ldn  approved  fda  multiple  sclerosis  generic  naltrexone  patent  protection  years  pharmaceutical  company  bear  expense  clinical  trials  fda  approval  ldnxs  special  public  institutions  seize  opportunity  ldn  offers  information  visit  www  ldnaware  org 